Singapore: Starpharma Holdings was named the industry's 2012 Australian company of the year. The Janssen 2012 Industry...
Singapore: Audeo Oncology, which has offices in Australia and the US, has appointed Ms Leigh Bonney, Dr Susan Kelley and...
Singapore: The University of Queensland's (UQ) Center for Online Health (COH) and natural gas developer QGC are jointly ...
Singapore: Canada-based Medworxx Solutions is expanding into Australia with its partner, EQhealth. Medworxx and EQhealt...
Singapore: Alchemia provided an update on its marketed generic anti-coagulant product, fondaparinux, which was launched...
Singapore: Regenerative medicine company, Avita Medical, has initiated a multicenter randomized control study on the us...
Singapore: At the recent international BIO Conference in Philadelphia, Queensland's Premier Ms Annastacia Palaszczuk ann...
Singapore: Australia-based Patrys, a clinical stage biotechnology company, has received confirmation of Orphan Medicinal...
Australia's biggest name in pharmaceutical industry CSL kept its focus on new product development, life-cycle management...
Singapore: Prima BioMed announced that the Saxony Development Bank in Dresden, Germany (the Sächsische Aufbaubank or...
‎Singapore: Australia's Algae.Tec has signed Memorandum of Understanding (MOU) with WorleyParsons for joint develo...
Singappore: Australia-based Spinifex Pharmaceuticals received an approximately $1.5 million R&D tax incentive cash r...
Singapore: Australia's peptide drug discovery company, Phylogica has received linkage grant from Australian Research Cou...
Singapore: Osprey Medical received US FDA 510(k) clearance for its Avert System, which is designed to reduce the amount ...
Singapore: Melbourne University entered into an agreement with Indonesian vaccine maker, Bio Farma, to develop a vaccine...
Singapore: Global natural healthcare company, Rapid Nutrition, appointed diversified investment and financial services ...
Singapore: AmpliPhi Biosciences, the anti-infective company focused on developing phage-based therapies to combat the g...
Singapore: Mesoblast has entered into agreements to raise $173.98 million (A$170 million) through an issue of new fully ...
